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Alteration of CD4
+CD25
+Foxp3
+ T cell level in 
Kawasaki disease
Purpose: Exaggerated pro-inflammatory reactions during the 
acute phase of Kawasaki disease (KD) suggest the role of immune 
dysregulation in the pathogenesis of KD. We investigated the profiles of 
T regulatory cells and their correlation with the clinical course of KD.
Methods: Peripheral blood mononuclear cells were collected from 
17 KD patients during acute febrile and subacute afebrile phases. T 
cells expressing CD4, CD25, and Foxp3 were analyzed using flow 
cytometry, and the results were correlated with the clinical course of 
KD.
Results: The percentage of circulating CD4
+CD25
highFoxp3
+ T cells 
among CD4
+ T cells was significantly higher during the subacute 
afebrile phase than during the acute febrile phase (1.10%±1.22% vs. 
0.55%±0.53%, P=0.049). Although levels of CD4
+CD25
lowFoxp3
+ 
T cells and CD4
+CD25
‒Foxp3
+ T cells were only slightly altered, the 
percentage of CD4
+CD25
+Foxp3
‒ T cells among CD4
+ T cells was 
significantly lower during the subacute afebrile phase than during 
the acute febrile phase (2.96%±1.95% vs. 5.64%±5.69%, P=0.036). 
Consequently, the ratio of CD25
highFoxp3
+ T cells to CD25
+Foxp3
‒ T 
cells was higher during the subacute afebrile phase than during the 
acute febrile phase (0.45%±0.57% vs. 0.13%±0.13%, P=0.038). 
Conclusion: Decreased CD4
+CD25
highFoxp3
+ T cells and/or an 
imbalanced ratio of CD4
+CD25
highFoxp3
+ T cells to CD4
+CD25
+ 
Foxp3
‒ T cells might play a role in KD development. Considering that 
all KD patients were treated with intravenous immunoglobulin (IVIG), 
recovery of CD4
+CD25
highFoxp3
+ T cells during the subacute afebrile 
phase could be a mechanism of IVIG. 
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Introduction
Kawasaki disease (KD) is a systemic vasculitis syndrome that 
features a high fever in infants and children. In Korea, 105 out of 
100,000 people contract it, and the incidence rate ranks second in the 
world after Japan
1). Despite numerous studies that have been carried 
out since it was reported first in 1967, the cause has not yet been 
established. As the causative pathogen has not been identified and 
excessive immune activation is observed in almost all patients during 
the acute phase of KD, we believe that abnormal immune activation 
from a nonspecific infection might be a possible cause.
The immune mechanism must maintain a balance between 
activation and suppression; specifically, when an infection occurs, 
the immune system is activated to remove the pathogen, but also 
regulated to preclude damage to autologous tissue. In the human 
body, various cells participate in the regulation of the immune 
response. Although CD25 and the forkhead family transcription 
factor (Foxp3) are the most representative markers for the T 
regulatory cells (Tregs), they are also expressed in activated T cells. 
Foxp3
+ T cells that do not express CD25 are unable to function 
properly as Tregs
2). Approximately 30% of human CD4
+ T cells 
express CD25 but only 1-3% express it at a high level, functioning 
as Tregs that suppress conventional T cell activation in a contact-
dependent, dose-dependent, and antigen-nonspecific manner
3, 4). In 
recent studies, dysregulation in CD4
+ Tregs with relatively high levels 
of CD25 (CD4
+CD25
highFoxp3
+ cells) has been demonstrated in 
various autoimmune diseases and cancer
3, 5-7). As immunoregulatory 
abnormality may be related to the cause of KD, we investigated the 
profiles of Tregs in acute KD as well as the changes of relative ratio 
correlated to the clinical course of KD.
The purpose of this study was to investigate the roles of cells that 
express CD4, CD25, and Foxp3 markers in KD. Accordingly, the 
expression pattern was analyzed in patients with KD that showed 
excessive immune activation during the acute phase, and the changes 
were related to the progress of the disease.
Materials and methods
1. Materials
This study was performed on 17 patients diagnosed with KD 
between March and November, 2008 at Korea University Medical 
Center Ansan Hospital. The cases were characterized by a fever 
of more than 38.5℃ that continued for at least 5 days and was 
accompanied by at least four out of the following five symptoms: 
polymorphous rash, extremity changes, cervical lymphadenopathy, 
conjunctival injection, and distinctive oral manifestations. Eight 
patients satisfied all the diagnostic criteria. In the other nine patients 
where the clinical manifestations did not fulfill the diagnostic 
criteria and other diagnoses were excluded, symptoms that are 
frequently associated with KD and elevated inflammatory indices 
during the acute phase were considered to support the diagnosis of 
incomplete KD
8, 9). These cases of incomplete KD were only included 
in this analysis if they showed a typical convalescent condition 
such as skin peeling. All 17 subjects were treated with intravenous 
immunoglobulin (IVIG, 2 g/kg) in addition to aspirin (50‒80 mg/
kg/day). Echocardiography was performed usually at 7‒10 days after 
onset of fever and thereafter at monthly intervals for at least 2 months. 
During this period, patients exhibiting any coronary abnormality, 
regardless of later resolution, were counted as having a coronary 
abnormality. In accordance with recommendations in a report from a 
subcommittee of the Japanese Research Committee on KD in 1984, 
a coronary artery abnormality is defined as a coronary artery diameter 
of at least 3 mm (those aged less than 5-years-old) or 4 mm (those 
aged 5 and older), and 1.5 times larger than the diameter of the closest 
blood vessel and an inner surface irregularity of the blood vessel
10). 
 
2. Methods
The peripheral blood of subjects was collected before the use of 
IVIG to bring down the fever and 2 days after defervescence, with the 
consent of their parents. After density-gradient centrifugation using 
a Ficoll centrifuges (Amersham Pharmacia, Biotech, Piscataway, 
NJ, USA), mononuclear cells were separated from peripheral blood. 
Mononuclear cells at a concentration of 1×10
6/100 µ L phosphate-
buffered saline were mixed with a cocktail of allophycocyanin 
(APC)-antihuman CD4 antibody and fluorescein isothiocyanate 
(FITC)-antihuman CD25 antibody (eBioscience, San Diego, CA, 
USA). The mixture was allowed to react at 4℃ for 30 min and 
was then rinsed with the phosphate-buffered saline. After 2 µ L of 
fixation and permeabilization solution was added, the mixture was 
allowed to further react at 4℃ for 30 min. Again, it was rinsed by 
the phosphate-buffered saline. In the same way, phycoerythin (PE)-
antihuman Foxp3 antibody (eBioscience, San Diego, CA, USA) 
was administered, marked, and rinsed. The subjects were classified 
into four groups, i.e., a control group, a group of mononuclear 
cells marked by antihuman CD4 and CD25 antibodies, a group 
marked by the antihuman Foxp3 antibody, and a group marked 
by both antihuman CD4 and CD25 antibodies and antihuman 
Foxp3 antibodies. The subjects were then analyzed by the use of flow 
cytometry (FACSCalibur, CellQuest software, Becton Dickinson 
Immunocytometry System, San Jose, CA, USA)
11). Expression of 
CD25 and Foxp3 were determined in gated CD4
+ T cells, and 
consequently each cell population was expressed as the percent of Korean J Pediatr 2011;54(4):157-162 • DOI: 10.3345/kjp.2011.54.4.157    159
CD4
+ T cells. Foxp3
+ T cells, based on their CD25 expression, 
were divided into three populations: CD4
+CD25
‒Foxp3
+ T cells, 
CD4
+CD25
lowFoxp3
+ T cells, and CD4
+CD25
highFoxp3
+ T cells (Fig. 
1). 
For statistical analysis, SPSS (version 12.0, SPSS Inc., Chicago, IL, 
USA) was used with the paired t-test. Only cases in which the P value 
was less than 0.05 were considered to be significant, and the data were 
expressed in ‘percentage (%)’ or ‘the mean±the standard deviation 
(SD)’.
 Results
1. Characteristics of subjects
The average age of the 17 subjects was 30.8±15.8 months, and the 
ratio of males to females was 10:7. Their fevers were lowered after a 
single dose of IVIG (2 g/kg). After the administration of IVIG, the 
febrile phase lasted 1.4±1.1 days on the average, and the whole period 
of fever was 6.9±1.4 days. Two out of 17 subjects were diagnosed with 
coronary artery abnormalities, and on the echocardiographic follow-
up performed 1 month later, both of them showed regression. The 
blood test showed that the hemoglobin and leukocyte levels decreased 
after defervescence but the platelet level increased. The erythrocyte 
sedimentation rate (ESR) increased but was not significant. C-reactive 
protein decreased remarkably after defervescence (Table 1).
2. The altered percentages of CD4
+Foxp3
+ and CD4
+Foxp3
‒ 
T cells in KD
The percentage of circulating CD4
+CD25
highFoxp3
+ T cells among 
the total CD4
+T cells was significantly higher during the subacute 
afebrile phase than during the acute febrile phase (1.10±1.22% 
vs 0.55±0.53%, P=0.049) (Fig. 2A). In contrast, the percentages 
of CD4
+CD25
lowFoxp3
+ T cell and CD4
+CD25
‒Foxp3
+ T cell 
populations did not show significant change (Fig. 2B, C). The 
proportion of CD4
+CD25
lowFoxp3
+ T cells in both phases was 
similar (acute febrile phase, 4.52±8.83%, subacute afebrile phase, 
4.11±5.69%, P=0.884). Although the percentage of CD4
+CD25
‒
Foxp3
+ T cells was decreased during the subacute afebrile phase, 
it was not significant (10.86±14.32% vs 12.69±11.12%, P=0.523). 
Furthermore, the percentage of CD25
+Foxp3
‒ T cells was decreased 
in the subacute afebrile phase compared to the acute febrile phase 
(2.96±1.95% vs 5.64±5.69%, P=0.036) (Fig. 2D).
3. The altered ratio of CD4
+Foxp3
+ T cell subsets to 
CD4
+CD25
+Foxp3¯ T cells
The relative ratio of each subset of CD4
+Foxp3
+ T cells to 
CD4
+CD25
+Foxp3
‒ T cells, which shows the balance between two 
groups, was determined (Fig. 3). The ratio of CD4
+CD25
highFoxp3
+ 
T cells to CD4
+CD25
+Foxp3
‒ T cells showed a significant low point 
during the acute febrile phase (0.13±0.13% vs 0.45±0.57%, P=0.038) 
(Fig. 3A) However, there were no significant differences in the ratios 
of CD4
+CD25
lowFoxp3
+ T cells and CD4
+CD25
‒Foxp3
+ T cells 
to CD4
+CD25
+Foxp3
‒ T cells between phases (acute febrile phase, 
Table 1. Comparison of the Laboratory Findings between acute febrile 
and subacute afebrile phases
Variables Acute Subacute P-value
Hb (g/dL) 11.3±0.8 10.7±0.6   0.002*
Hct (%) 31.9±2.3 30.7±1.9   0.031*
WBC (K/L) 16.1±5.1  9.0±4.5 <0.001*
Platelet count (K/L)  431.8±103.9  606.3±166.1 <0.001*
ESR (mm/hr) 108.4±19.2 114.3±11.4   0.118
CRP (mg/dL) 13.6±9.9  3.0±2.1 <0.001*
Abbreviations: Hb, hemoglobin; Hct, hematocrit; WBC, white blood cell; 
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
*P<0.05 was considered significant
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Fig. 1. Human peripheral blood mononuclear cells were stained with antihuman CD4/
CD25 antibody. Quadrant lines demarcate the isotype control. (A) The right quadrant 
region (arrow) shows the percentage of CD4
+ T cells. (B) Representative dots show 
the expression of CD25 and Foxp3 on gated CD4
+ T cells. On the basis of their CD25 
expression, CD4
+ T cells are divided into 3 populations: CD25
high (R1), CD25
low (R2), 
CD25¯ (R3). R4 represents CD25
+Foxp3¯ T cells. 160      SY Sohn, et al. • Alteration of CD4
+CD25
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+ T cell level in Kawasaki disease
1.58±2.84%, subacute afebrile phase, 6.11±16.21%, P=0.282; acute 
febrile phase, 4.82±4.81%, subacute afebrile phase, 32.18±102.81%, 
P=0.288, Fig. 3B and 3C, respectively).
Discussion
CD25 and Foxp3 are the principal markers of Tregs but are 
simultaneously expressed in activated T cells; for that reason it is not 
easy to distinguish Tregs from activated T cells. It is not yet clear 
A B
C D
Fig. 2. The percentage of CD4
+Foxp3
+ T cell subsets and CD4
+Foxp3¯ T cells 
out of CD4
+ T cells during the acute febrile and subacute afebrile phases 
of Kawasaki disease. (A) CD25
highFoxp3
+ T cells, (B) CD25
lowFoxp3
+ T cells, 
(C) CD25¯Foxp3
+ T cells, (D) CD25
+Foxp3¯ T cells. The box represents the 
interquartile range with the median bar, and T-bars represent the 5th to 95th 
percentile interval. 
A B
C
Fig. 3. The ratio of CD4
+Foxp3
+ T cell subsets to CD4
+Foxp3¯ T cells during 
the acute febrile and subacute afebrile phases of Kawasaki disease. The 
ratio is defined as the percentage of the indicated T cell subset divided by the 
percentage of CD25
+Foxp3¯ T cells. The box represents the interquartile range 
with the median bar, and T-bars represent the 5th to 95th percentile interval. Korean J Pediatr 2011;54(4):157-162 • DOI: 10.3345/kjp.2011.54.4.157    161
whether all Tregs express Foxp3 and whether all Foxp3-expressing 
cells are Tregs. It is impossible to analyze the function of Foxp3
+ 
cells, because it is expressed intracellularly and its identification 
requires the fixation and permeabilization of cells. In this study, 
CD4
+Foxp3
+ Tregs were divided into CD25
high T cells, CD25
low T 
cells, and CD25
‒ T cells according to the degree of expression of 
CD25, and the numerical pattern of expression in these cells was 
correlated with the clinical courses of KD. During the acute phase, 
the proportion of CD4
+CD25
highFoxp3
+ T cells was lower than that 
during the subacute phase, which clinically corresponded to their 
suppressive regulatory function. However, in the case of CD25
low or 
CD25
‒ expression, the proportion of Foxp3
+ cells decreased, instead, 
during the subacute phase compared to the acute phase, although it 
was not significant. These results imply that the function of Foxp3
‒
expressing cells as Tregs needs to be further examined. There has 
been considerable controversy over the role of CD25
low T cells and 
CD4
+CD25
‒foxp3
+ T cells. Recently, it was suggested that these 
cells reflect the self-limiting nature of KD, acting as induced Tregs 
that have immunoregulatory function
12), but on the other hand it 
has been reported that these cells are like Tregs from the viewpoint 
of phenotype, but are more like activated T cells on the basis of 
function
13, 14). According to studies on systemic lupus erythematosus 
(SLE) patients, CD4
+CD25
highFoxp3
+ T cells decreased during the 
acute period, but CD4
+CD25
lowFoxp3
+T cells and CD4
+CD25
‒
Foxp3
+ T cells increased with the severity of the disease
7). In the 
process of reactivation, CD25
‒Foxp3
+ T cells re-express CD25 and 
thus function as a peripheral reservoir of CD25
+Foxp3
+ Tregs and 
restricted regulatory cells
2, 15). Consequently, it is supposed that at 
the very least, CD25
‒Foxp3
+ T cells are not fully functional Tregs. 
Furthermore, the relative increase of CD25
+Foxp3
‒ T cells during 
the acute phase might reflect immunoactivation in KD through 
their action as T effector cells. Considering the importance of ho-
meo  static balance in immunoregulation, it is meaningful to mea-
sure not only the change in level of each Tregs, but also the ratio 
of CD4
+CD25
+Foxp3
‒ T cells to each type of Foxp3
+ T cells. In 
patients with SLE, the percentages of CD4
+CD25
highFoxp3
+ T 
cells, CD4
+CD25
lowFoxp3
+ T cells, and CD4
+CD25
+Foxp3
‒ T 
cells increase in inverse proportion to the severity of the disease as 
compared to healthy controls
7, 16). In our study, CD4
+CD25
+Foxp3
‒ T 
cells decreased but CD4
+CD25
highFoxp3
+ T cells increased during the 
subacute afebrile phase of KD, resulting in a significantly heightened 
ratio that correlated with a decrease in the severity of the disease. The 
ratio of CD4
+CD25
lowFoxp3
+ T cells to CD4
+CD25
+Foxp3
‒ T cells 
was also heightened but was not significant.
All of the subjects were treated with IVIG, and a series of changes 
were expected after defervescence. One working mechanism of IVIG 
is to bind to cells that secrete inflammatory cytokines and chemokines 
and suppress the secretion
17). In addition, IVIG directly recovers the 
suppressive function of Tregs. IVIG binds more strongly to Tregs 
than to conventional T cells and induces an increase in Tregs both 
functionally and numerically
17, 18). Treg levels increased in the spleen 
after IVIG, caused by the expansion of preexisting Tregs rather than 
de novo generation
18). In addition to the induction of expression of 
Foxp3, as well as to the secretion of immunosuppressive TGF- β  and 
IL-10, IVIG increases the proportion of CD4
+CD25
highFoxp3
+ T 
cells
19). Corticosteroid and infliximab, which are cited as alternative 
treatments for intractable KD, increase the level of Tregs in some 
cases
20, 21). In the mean time, a therapy to directly induce Tregs 
in human patients suffering from allergies, by the use of specific 
‘probiotic’ bacteria to build autoimmunity
22, 23), could serve as a model 
for a possible alternative treatment for KD.  
In many cases, serious coronary artery complications are re  lated 
to a lengthy inflammatory condition. Brown et al.
4) who performed 
autopsies on eight children that died during the acute phase of KD 
reported an increase in the transmural infiltration of proinflammatory 
T cells such as CD8
+cytotoxic T cells and CD4
+ T helper 1 cells. In 
other studies, coronary artery complications readily occurred upon 
increased cytokine secretion from T cell activation
24-26). In our study, 
two subjects had coronary artery complications. Although these 
patients did not show a remarkable decrease of CD4
+CD25
highFoxp3
+ 
T cells or a remarkable increase of CD4
+CD25
+Foxp3
‒ T cells during 
the acute febrile phase, the ratio of CD4
+CD25
highFoxp3
+ T cells to 
CD25
+Foxp3
‒ T cells was relatively low and CD4
+CD25
highFoxp3
+ 
T cells were not conspicuously recovered during the subacute afebrile 
phase (data not shown). More human studies are needed to more fully 
elucidate the role of CD4
+CD25
highFoxp3
+T cells in the development 
of coronary abnormalities.
In conclusion, decreased CD4
+CD25
highFoxp3
+ T cells, increased 
CD4
+CD25
+Foxp3
‒ T cells, and/or an imbalanced ratio of CD25 
highFoxp3
+ T cells to CD4
+CD25
+Foxp3
‒ T cells might be related to 
the immune activation that occurs during the acute phase of KD. 
Reversal of these parameters which was observed during the subacute 
afebrile phase, is likely a result of the treatment with IVIG. To define 
the roles of Tregs in the pathogenesis of KD, further studies that 
include normal controls as well as other febrile disease controls are 
needed.
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